Clinical sighificance of Blood glucose, AFP and cholinesterase levels on the early diagnosis and prognosis of severe hepatitis patients / 中国基层医药
Chinese Journal of Primary Medicine and Pharmacy
;
(12): 175-176, 2011.
Artículo
en Chino
| WPRIM
| ID: wpr-402096
ABSTRACT
Objective To study clinical value of blood glucose, AFP and cholinesterase levels on the diagnosis and prognosis of severe hepatitis. Methods Retrospective analysis of chronic hepatitis B, cirrhosis, chronic severe hepatitis, subacute severe hepatitis was carried out. In severe hepatitis patients, between the improved group and death group, blood glucose, AFP, cholinesterase differences, evaluate blood glucose, alpha-fetoprotein, cholinesterase levels on the diagnosis and prognosis of severe hepatitis value were compared. Results Subacute severe hepatitis, chronic severe hepatitis patients and blood cholinesterase levels were significantly lower than that in patients with chronic hepatitis B and liver cirrhosis(all P < 0.05) ;and alpha-fetoprotein level was significantly higher than the level of chronic hepatitis B patients(P < 0. 01) ;improved levels of blood glucose in patients with severe hepatitis, AFP, cholinesterase levels were significantly higher than the level of death group (all P < 0.05). Conclusion Blood glucose, AFP, cholinesterase levels of liver disease progression and prognosis were important to determine the value.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Tipo de estudio:
Estudio diagnóstico
/
Estudio pronóstico
/
Estudio de tamizaje
Idioma:
Chino
Revista:
Chinese Journal of Primary Medicine and Pharmacy
Año:
2011
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS